BIOMIND LABS INC. (3XI) — Cash Flow-to-Debt Ratio
BIOMIND LABS INC. (3XI) has a Cash Flow-to-Debt Ratio of -0.02x as of September 2025, meaning its operating cash flow of €-38.70K could theoretically repay 0% of its total liabilities (€1.62 Million) in one year. See BIOMIND LABS INC. free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
BIOMIND LABS INC. Cash Flow-to-Debt Ratio (2021–2024)
Historical debt coverage capacity for BIOMIND LABS INC. across 4 annual periods. Also explore 3XI net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for BIOMIND LABS INC. (2021–2024)
Year-by-year debt coverage analysis for BIOMIND LABS INC.. For market capitalisation and broader financial context, see BIOMIND LABS INC. market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.26x | €-354.43K | €1.34 Million | ▲ +48.0% |
| 2023 | -0.51x | €-765.93K | €1.51 Million | ▲ +92.0% |
| 2022 | -6.39x | €-2.15 Million | €336.72K | ▼ -0.8% |
| 2021 | -6.34x | €-2.12 Million | €334.95K | — |